{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:15:33Z","timestamp":1792887333705,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research, Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioadv.2026.214835","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:42:11Z","timestamp":1773913331000},"page":"214835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Nose-to-brain delivery of berberine-loaded nanoemulsion: Amelioration of brain targeting, behavioral, pharmacokinetic, and biodistribution insights for Alzheimer's intervention"],"prefix":"10.1016","volume":"184","author":[{"given":"Mansi","family":"Negi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etikala","family":"Amulya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Phatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2026.214835_bb0005","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"Deture","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bioadv.2026.214835_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bioadv.2026.214835_bb0015","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer\u2019s disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioadv.2026.214835_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123155","article-title":"Surface engineered nano architectonics: an evolving paradigm for tackling Alzheimer\u2019s disease","volume":"358","author":"Negi","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bioadv.2026.214835_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.18773\/austprescr.2024.021","article-title":"New and emerging drug therapies for Alzheimer disease","volume":"47","author":"Waite","year":"2024","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.bioadv.2026.214835_bb0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214835_bb0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s40001-024-01915-3","article-title":"Alzheimer\u2019s disease and drug delivery across the blood-brain barrier: approaches and challenges","volume":"29","author":"Iqbal","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bioadv.2026.214835_bb0040","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1007\/s10787-025-01923-7","article-title":"Unlocking therapeutic potential in traumatic brain injury: exploring microenvironmental targets, signaling pathways and translational hurdles","volume":"33","author":"Bahuguna","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bioadv.2026.214835_bb0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jconrel.2023.01.031","article-title":"Nanomedicine based strategies for oligonucleotide traversion across the blood\u2013brain barrier","volume":"354","author":"Amulya","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214835_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111654","article-title":"Nanoparticles for targeted brain drug delivery: what do we know?","volume":"22","author":"Pinheiro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2026.214835_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12101883","article-title":"Neuroprotective properties of berberine: molecular mechanisms and clinical implications","volume":"12","author":"Tian","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioadv.2026.214835_bb0060","article-title":"Natural bioactive compounds form herbal medicine in Alzheimer\u2019s disease: from the perspective of GSK-3\u03b2","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040481","article-title":"Nasal delivery to the brain: harnessing nanoparticles for effective drug transport","volume":"16","author":"Gandhi","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.214835_bb0070","article-title":"Intranasal delivery of transferrin conjugated chitosan nanoparticles to the brain: a comparative analysis of conjugated and un-conjugated nanoparticles in vivo","volume":"104","author":"Annu","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0075","series-title":"Biomater. Nanomed. Target. Ther.","first-page":"305","article-title":"Nano-biomaterial-assisted targeted therapy of central nervous system disorders","author":"Phatale","year":"2024"},{"key":"10.1016\/j.bioadv.2026.214835_bb0080","article-title":"Lipid engineered nanomaterials: a novel paradigm shift for combating stroke","volume":"38","author":"Amulya","year":"2024","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.bioadv.2026.214835_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/0974-7788.76789","article-title":"Validated HPLC-UV method for the determination of berberine in raw herb Daruharidra (Berberis aristata DC), its extract, and in commercially marketed ayurvedic dosage forms","volume":"1","author":"Pasrija","year":"2010","journal-title":"Int. J. Ayurveda Res."},{"key":"10.1016\/j.bioadv.2026.214835_bb0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13346-024-01565-2","article-title":"High mobility group box 1 cytokine targeted topical delivery of resveratrol embedded nanoemulgel for the management of atopic dermatitis","volume":"15","author":"Nene","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioadv.2026.214835_bb0095","article-title":"Exploring the therapeutic potential of functional excipient-based nanoemulgel of fluticasone propionate for the management of psoriasis","volume":"84","author":"Jain","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0100","article-title":"Topical delivery of tofacitinib citrate loaded novel nanoemulgel for the management of 2,4-Dichlorodinitrobenzene induced atopic dermatitis in mice model","volume":"80","author":"Atmakuri","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071030","article-title":"Water-in-oil nano-emulsions prepared by spontaneous emulsification: new insights on the formulation process","volume":"13","author":"Akram","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.214835_bb0110","article-title":"Transdermal delivery and exploration of preclinical anti-rheumatoid efficacy of pirfenidone embedded nanoemulgel in adjuvant-induced rat model","volume":"93","author":"Nooreen","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0115","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1039\/D0RA06080A","article-title":"Design and characterization of oil-in-water nanoemulsion for enhanced oil recovery stabilized by amphiphilic copolymer, nonionic surfactant, and LAPONITE\u00ae RD","volume":"11","author":"Zhao","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2026.214835_bb0120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12668-022-00964-4","article-title":"Nanoemulsions (O\/W) containing Cymbopogon pendulus essential oil: development, characterization, stability study, and evaluation of in vitro anti-bacterial, anti-inflammatory, anti-diabetic activities","volume":"12","author":"Agnish","year":"2022","journal-title":"Bionanoscience"},{"key":"10.1016\/j.bioadv.2026.214835_bb0125","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jsps.2021.11.006","article-title":"Intranasal delivery of clozapine using nanoemulsion-based in-situ gels: an approach for bioavailability enhancement","volume":"29","author":"Abdulla","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioadv.2026.214835_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124376","article-title":"Therapeutic potential of limonene-based syringic acid nanoemulsion: enhanced ex-vivo cutaneous deposition and clinical anti-psoriatic efficacy","volume":"660","author":"Assalem","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2026.214835_bb0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/21691401.2014.887018","article-title":"Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether","volume":"43","author":"Laxmi","year":"2015","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09925","article-title":"Nose to brain delivery of nanosuspensions with first line antiviral agents is alternative treatment option to neuro-AIDS treatment","volume":"8","author":"Kakad","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bioadv.2026.214835_bb0145","article-title":"Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs","volume":"2023","author":"Preeti","year":"2023","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.bioadv.2026.214835_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104165","article-title":"Protective effects of SGB121, ginsenoside F1-enriched ginseng extract, on scopolamine-induced cytotoxicity and memory impairments","volume":"74","author":"Bastola","year":"2020","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bioadv.2026.214835_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141136","article-title":"Chitosan-coated nanostructured lipid carriers for intranasal delivery of sinapic acid in A\u03b21\u201342 induced C57BL\/6 mice for Alzheimer\u2019s disease treatment","volume":"305","author":"Prabakaran","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2022.09.024","article-title":"Quality by design steered development of niclosamide loaded liposomal thermogel for melanoma: in vitro and ex vivo evaluation","volume":"180","author":"Shah","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2026.214835_bb0165","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ar.24214","article-title":"Picroside II protects SH-SY5Y cells from autophagy and apoptosis following oxygen glucose deprivation\/reoxygen injury by inhibiting JNK signal pathway","volume":"302","author":"Wang","year":"2019","journal-title":"Anat. Rec."},{"key":"10.1016\/j.bioadv.2026.214835_bb0170","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4103\/1673-5374.215262","article-title":"Neuroprotection of N-benzylcinnamide on scopolamine-induced cholinergic dysfunction in human SH-SY5Y neuroblastoma cells","volume":"12","author":"Puangmalai","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bioadv.2026.214835_bb0175","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijpharm.2017.07.030","article-title":"Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion","volume":"529","author":"Abdou","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2026.214835_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119499","article-title":"Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: in vitro and in vivo studies for brain targeting","volume":"586","author":"Kumbhar","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2026.214835_bb0185","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/10717544.2022.2036870","article-title":"The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics","volume":"29","author":"Yu","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2026.214835_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00665","article-title":"Amelioration ofc ognitive deficit by embelin in a scopolamine-induced Alzheimer\u2019s disease-like condition in a rat model","volume":"9","author":"Bhuvanendran","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176960","article-title":"Faecalibacterium prausnitzii, FOS and GOS loaded synbiotic reverses treatment-resistant depression in rats: restoration of gut-brain crosstalk","volume":"983","author":"Palepu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120141","article-title":"Matricaria Chamomilla L. leaf and flower extracts improved scopolamine-induced amnesia via regulation of cholinergic dysfunction and brain antioxidant status: an in-vivo and in-silico study","author":"Khan","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2025.101131","article-title":"Polyherbal formulation mitigates age-associated cognitive deficits in rats","volume":"16","author":"Dandekar","year":"2025","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.bioadv.2026.214835_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176436","article-title":"Chitosan revokes controlled-cortical impact generated neurological aberrations in circadian disrupted mice via TLR4-NLRP3 axis","volume":"969","author":"Bazaz","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214835_bb0215","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1021\/acschemneuro.0c00430","article-title":"Biophysical, biochemical, and behavioral implications of ApoE3 conjugated donepezil nanomedicine in a A\u03b21-42Induced Alzheimer\u2019s disease rat model","volume":"11","author":"Krishna","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bioadv.2026.214835_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s42826-023-00187-y","article-title":"The memory ameliorating effects of novel N-benzyl pyridine-2-one derivatives on scopolamine-induced cognitive deficits in mice","volume":"40","author":"Pant","year":"2024","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.bioadv.2026.214835_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00250","article-title":"The McGill transgenic rat model of Alzheimer\u2019s disease displays cognitive and motor impairments, changes in anxiety and social behavior, and altered circadian activity","volume":"10","author":"Petrasek","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioadv.2026.214835_bb0230","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1021\/acs.molpharmaceut.3c00454","article-title":"Simultaneous intranasal codelivery of donepezil and memantine in a nanocolloidal carrier: optimization, pharmacokinetics, and pharmacodynamics studies","volume":"20","author":"Handa","year":"2023","journal-title":"Mol. Pharm."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:36:36Z","timestamp":1778934996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S2772950826001330"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214835","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of berberine-loaded nanoemulsion: Amelioration of brain targeting, behavioral, pharmacokinetic, and biodistribution insights for Alzheimer's intervention","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214835"}}